Furthermore, microbubble accumulation was significantly higher in the disease model compared to wild-type controls, which suggested that elevated VCAM-1 and MAdCAM-1 expression following colitis induction mediated the inflammation-dependent binding and drug delivery of the targeted microbubble system [123]. The gene discussed is MADCAM1; the disease is colitis.